AMO Pharma - 2023 Meet the DM Drug Developers

Presented July 7, 2023.

Each month biotechnology, pharmaceutical and academic partners, large and small, working on treatments and a cure for myotonic dystrophy will sit down with our community to share their progress and answer your questions. Click here to learn more about AMO Pharma.

Click here to find all our upcoming Meet the DM Drug Developers dates!

Presenters Include

Michael Snape, PhD
Chief Scientific Officer

Dr. Snape is a neurobiologist who has spent 27 years in the pharmaceutical industry working for large and emerging biopharmaceutical companies. He has experience founding and funding companies at inception through IPO on the public markets. His principal experience lies in the area of demonstrating clinical proof-of-concept with novel targeted therapeutics in rare diseases. He is named an inventor in numerous patents and is a scientific advisor to several patient foundations. He earned a PhD in neurobiology from London University after study at Maudsley and Bethlem Hospital and holds a faculty position at Case Western University.


Joe Horrigan, MD
Chief Medical Officer

Dr. Horrigan is a pediatric neuropsychiatrist. He has 20 years of experience in the pharmaceutical and biotech industry, both as a clinical investigator and as a sponsor. Dr. Horrigan was a Senior Director in the Neurosciences Medicines Development Center at GlaxoSmithKline, where he also co-founded and led the company-wide Medicines for Children Advisory Network that collaborated with all therapeutic areas in the company. Dr. Horrigan also served as Assistant Vice President and Head of Medical Research for Autism Speaks, the largest science and advocacy organization in the U.S. devoted to autism spectrum disorders (ASD). Most recently, he has served as Vice President of Clinical Development and Medical Affairs for Neuren Pharmaceuticals Limited, leading that company’s clinical development efforts in neurodevelopmental disorders and traumatic brain injury. Dr. Horrigan received his Sc.B. degree from Brown University and his medical degree from the University of Rochester. Dr. Horrigan is also a Clinical Associate Professor at the University of North Carolina.

© Myotonic Dystrophy Foundation. All rights reserved.